1Q 2020 update | AEX:AGN | NYSE:AEG
![](/sites/default/files/contentassets/ac21865a048e49e08b0aa2d411a8ca29/content-banner-woman-laptop.jpg)
Net income of EUR 1,270 million, reflecting fair value gains
- Underlying earnings before tax were EUR 366 million reflecting adverse mortality and impacts from lower interest rates in the Americas, and limited COVID-19 related non-life claims in the Netherlands
- Net income of EUR 1,270 million reflects fair value gains of EUR 1,372 million, driven by a reduction in the valuation of the liabilities in the Netherlands, reflecting wider credit spreads. This was partly offset by fair value losses in the US from unhedged risks on variable annuities and underperformance of investments. Hedge programs across the group were highly effective for the targeted risks
- Other charges of EUR 162 million mainly related to a provision for a class action settlement, restructuring charges, and IFRS 9 / 17 project costs, partly offset by a gain on sale of Aegon’s stake in joint ventures in Japan
- Return on equity of 7.0% in the first quarter of 2020; very unlikely to reach annual 10% return on equity target, given the extraordinary circumstances due to the COVID-19 pandemic
Gross deposits of EUR 52 billion; net outflows of EUR 1 billion
- Gross deposits were EUR 52 billion; net outflows of EUR 1 billion caused by Variable Annuities and Mutual Funds in the Americas, partly offset by third-party inflows at Asset Management
- New life sales were EUR 206 million; sales in the US were under competitive pressure and impacted by the phasing out of certain whole life products, while sales in China benefitted from the e-commerce sales model
- Accident & health insurance new premium production was EUR 76 million and property & casualty new premium production was EUR 36 million
Solid capital and Holding excess cash position
- Solvency II ratio increased to 208%, as the negative impact of market movements in the US was more than offset by normalized capital generation and the benefit of a higher EIOPA volatility adjustment in the Netherlands
- The capital positions in each of Aegon’s three main units remained above the bottom end of their respective target ranges
- Normalized capital generation after holding expenses was EUR 311 million
- Holding excess cash increased to EUR 1.4 billion, driven by a EUR 100 million remittance from the Netherlands and EUR 153 million proceeds from the sale of Aegon’s stake in joint ventures in Japan
Statement of Matt Rider, CFO
“Given the extraordinary circumstances due to the COVID-19 pandemic, we provide a condensed update of our results today. In the first quarter of 2020, underlying earnings in Europe, Asia and Asset Management held up well. However, earnings in the United States were negatively affected by the drop in interest rates as a result of the COVID-19 crisis, and unfavorable mortality experience, which was largely unrelated to COVID-19. This resulted in underlying earnings before tax of 366 million euros for the Group. Net income of 1.3 billion euros benefited from effective hedge programs and the favorable impact of credit spread movements on the valuation of our liabilities.
We are acutely aware of the disruption that the COVID-19 pandemic has caused for our customers, employees and the communities in which we operate. Our priority is to protect the health, safety and security of our employees, and fulfill our responsibilities towards all our stakeholders. I am pleased to say that our resilience, experience and business continuity plans have enabled us to serve our customers at a high level. Our purpose, to help them achieve a lifetime of financial security, remains the same
The uncertainty around how the pandemic will play out and the continued economic impact it will have, make it difficult to provide a full assessment of COVID-19 related impacts on our medium-term targets, while it is very unlikely that we will reach our annual 10% return on equity target in 2020.
I am pleased that we have maintained a strong balance sheet and liquidity position at the Group and in our main units in these extraordinary times. We are taking management actions to protect the economic value of the balance sheet and our capital position, and are looking at opportunities to increase our cost efficiency. Our aim is to position the company well as we emerge from the COVID-19 crisis to ensure the best possible outcome for all our stakeholders.”
.